BLFS Oct 2024 22.500 call

OPR - OPR Delayed price. Currency in USD

Add to watchlist

2.8000

0.0000

(0.00%)

As of 11:23AM EDT. Market open.

Loading interactive chart…

GuruFocus.com
Insider Sale: Todd Berard Sells 10,000 Shares of BioLife Solutions Inc (BLFS)
Todd Berard, Chief Marketing Officer of BioLife Solutions Inc (NASDAQ:BLFS), executed a sale of 10,000 shares of the company on June 14, 2024.
Zacks
BioLife (BLFS) Progresses in Cell & Gene Therapy With CryoCase
BioLife's (BLFS) latest product, CryoCase, is compatible with various downstream processing systems, including its own Signata CT-5.
PR Newswire
BioLife Solutions Introduces the CellSeal CryoCase™ at International Society for Cell & Gene Therapies (ISCT) Conference in Vancouver
BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of bioproduction tools and services for the cell and gene therapy (CGT) and broader biopharma markets, today announced the introduction of the CryoCase, an addition to its CellSeal product line.